Pharmacological and Endoscopic Interventions for Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.

Gastroenterology Res · 2023 · PMC10284647 · PMID 37351082

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP = 0.24not close (p > 0.1)

Post-ERCP pancreatitis frequency was 2.1% and 0.62% in the non-statin and statin groups, respectively; it did not reach statistical significance (P = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.